Free fatty acids, which are elevated in NASH patients [106], have been suggested to function as DAMPs and together with TLR ligands activate the NLRP3 inflammasome [63,107]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.